B2M and myeloid sarcoma: Differential gene expression between mild and severe MS phenotypes in the discovery and validation cohorts; mean counts were determined by RNA-seq (number of sequenced fragments) and by ddPCR (number of gene copies, normalized to HPRT1 and B2M expression), respectively.